可孚医疗 (301087)
Cofoe Medical Technology Co.,Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 20889.70
- Circulating A-Shares(W): 19424.70
- Earnings Per Share(RMB): 1.2800
- Net Assets Per Share(RMB): 22.5645
- Operating Revenue(W RMB): 239779.19
- Total Profit(W RMB): 30417.71
- Net Profit Attributable to Parent(W RMB): 26021.73
- Net Profit Growth Rate(%): 3.30
- Weighted Return on Equity(%): 5.2900
- Operating Cash Flow Per Share(RMB): 2.8240
- Undistributed Profit Per Share(RMB): 3.1516
- Capital Reserve Per Share(RMB): 18.8979
2. Main Business
The main business covers:
- R&D, production, sales and service of medical devices
3. Company Basic Information
- Company Name: Cofoe Medical Technology Co., Ltd.
- Listing Date: 2021-10-25
- Industry: Medical & Pharmaceutical - Medical Devices / Special Purpose Equipment Manufacturing
- Address: No. 816 Zhenhua Road, Yuhua District, Changsha City, Hunan Province
- Website: www.cofoe.com.cn
- Company Profile: The company was established through the overall change of Cofoe Co., Ltd. into a joint stock company. On December 25, 2019, Cofoe Co., Ltd. held a shareholders' meeting where all shareholders unanimously agreed to transform the company into a joint stock company. Based on the audited net assets of Cofoe Co., Ltd. as of October 31, 2019, amounting to 550.6967 million yuan, the company's shares were converted at a ratio of 1:0.2179, resulting in 120 million shares. On December 26, 2019, the company obtained the "Business License" issued by the Changsha Market Supervision and Administration Bureau with the unified social credit code 91430111696240992G.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Changsha Xiezihao Medical Investment Co., Ltd. | General Legal Person | 8507.99 | 43.80 |
| 2 | Changsha Keyuan Tongchuang Venture Capital Partnership (Limited Partnership) | General Legal Person | 1211.49 | 6.24 |
| 3 | Ningbo Huaige Health Investment Management Partnership (Limited Partnership)-Ningbo Huaige Gongxin Venture Capital Partnership (Limited Partnership) | Asset Management Plan | 444.98 | 2.29 |
| 4 | Huagai Capital Co., Ltd.-Capital Health Industry (Beijing) Fund (Limited Partnership) | Asset Management Plan | 418.18 | 2.15 |
| 5 | Changsha Yuhua Economic Development Dingxin Private Equity Fund Partnership (Limited Partnership) | General Legal Person | 213.31 | 1.10 |
| 6 | Xiangtan Chanxing Dingxin Private Equity Fund Enterprise (Limited Partnership) | General Legal Person | 209.94 | 1.08 |
| 7 | Guotai Pharmaceutical Health Equity Securities Investment Fund Class A | Fund | 165.18 | 0.85 |
| 8 | Guotai Great Health Equity Securities Investment Fund Class A | Fund | 77.36 | 0.40 |
| 9 | Guotai Research Selection Two-Year Holding Period Hybrid Securities Investment Fund | Fund | 40.27 | 0.21 |
| 10 | Xingyin Smart Selection Consumption Hybrid Securities Investment Fund Class A | Fund | 8.38 | 0.04 |
5. Concept Sectors
- Aging Care Concept
- Alibaba Concept
- Smart Healthcare
- Helicobacter Pylori
- Pulse Oximeter
- Synthetic Biology
- DeepSeek
- Margin Trading & Securities Lending
- High-Performance Stock
- Below IPO Price
- Specialized, Refined, Distinctive, and Innovative (SRDI)
- High Dividend Stock
- ChiNext Small Cap
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information